Through our committed advocacy network, AIM has helped secure substantial increased investment in Alzheimer’s and dementia research funding since the passage of the National Alzheimer’s Project Act (NAPA). Following a $100 million increase signed into law in March 2024, and added to current NIH spending, annual federal funding for Alzheimer’s research will be as much as $3.8 billion, up from under $500 million annually when NAPA was passed.

FY24 funding chart

As a result of this unprecedented funding, scientists are able to work at a more rapid pace to advance basic disease knowledge, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments.

For decades, millions of Americans and their families have waited for improved, effective therapies for Alzheimer’s and other dementia. Around the globe, researchers are working to find solutions for those facing the crushing realities of this relentless disease.

Thanks to our tireless advocates, AIM helped achieve today’s unprecedented levels of Alzheimer’s research funding. This funding is directly empowering scientists to explore a wide variety of pathways that could yield promising new therapies for people living with Alzheimer’s in the future.

It’s an exciting time for Alzheimer’s and dementia research. At any given moment, discovery is happening. Learn more about these exciting developments in Realizing the National Plan to Address Alzheimer’s Disease: Leadership Toward Treatment and Prevention.


Two Advocates Outside

Be a Champion in the Fight to End Alzheimer’s

Our voices are stronger together. Help AIM advance legislation to improve the lives of people impacted by Alzheimer’s and all other dementia.

  • Share your story with elected officials
  • Engage on social media
  • Write a letter to the editor

Federal Priorities

A National Response to Alzheimer’s and Other Dementia

The bipartisan NAPA Reauthorization Act and the Alzheimer’s Accountability and Investment Act would build on the progress made over the last decade by continuing to promote rapid research and improve the delivery of clinical care and services for people living with Alzheimer’s.

Our Nation’s Commitment to Alzheimer’s Research and Public Health Response

Congress must continue to invest in Alzheimer’s and dementia research at the National Institutes of Health (NIH), and fund the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (P.L. 115-406) to strengthen the public health infrastructure across the country by implementing effective Alzheimer’s intervention focused on public health issues such as increasing early detection and diagnosis, reducing risk, and preventing avoidable hospitalizations.